机译:分析肝细胞癌中的Notfamily基因表达,临床病理特征和预后价值
Shanxi Med Univ Taiyuan Peoples R China;
Shanxi Med Univ Taiyuan Peoples R China;
Shanxi Med Univ Taiyuan Peoples R China;
Shanxi Med Univ Taiyuan Peoples R China;
Shanxi Med Univ Taiyuan Peoples R China;
Shanxi Med Univ Shanxi Bethune Hosp Dept Gen Surg Taiyuan 030032 Shanxi Peoples R China;
Shanxi Med Univ Shanxi Bethune Hosp Dept Gen Surg Taiyuan 030032 Shanxi Peoples R China;
Shanxi Med Univ Shanxi Bethune Hosp Dept Gen Surg Taiyuan 030032 Shanxi Peoples R China;
Shanxi Med Univ Shanxi Bethune Hosp Dept Gen Surg Taiyuan 030032 Shanxi Peoples R China;
Shanxi Med Univ Shanxi Bethune Hosp Dept Gen Surg Taiyuan 030032 Shanxi Peoples R China;
Shanxi Med Univ Shanxi Bethune Hosp Dept Gen Surg Taiyuan 030032 Shanxi Peoples R China;
Shanxi Med Univ Shanxi Bethune Hosp Dept Gen Surg Taiyuan 030032 Shanxi Peoples R China;
CNOT; hepatocellular carcinoma; clinicopathological features; prognosis;
机译:脂肪变化的肝细胞癌的临床病理学特征:癌性脂肪变性的肿瘤具有更好的预后和Perilipin和Adipophilin的性异常表达模式
机译:MicroRNA 638和性别测定区域Y型盒2在肝细胞癌中的表达:临床病理特征与预后的关联
机译:叉头箱M1转录因子的表达增加与临床病理特征有关,并赋予人类肝细胞癌的预后差
机译:随机森林特征选择对肝细胞癌基因表达数据分类的比较性能评价
机译:HCV阳性肝细胞癌患者肿瘤组织和非肿瘤组织表观遗传和基因表达终点的比较分析。
机译:PDK1表达与肝细胞癌临床病理特征及预后的关系
机译:MicroRNA 638和性别测定区域Y型盒2在肝细胞癌中的表达:临床病理特征与预后之间的关联
机译:基因组全基因表达对前列腺癌预后的综合分析。